AMMONIA N 13 and DEPRESSION

Overview

DEPRESSION is the #3 most commonly reported adverse reaction for AMMONIA N 13, manufactured by 3D Imaging Drug Design and Development LLC. There are 6 FDA adverse event reports linking AMMONIA N 13 to DEPRESSION. This represents approximately 2.3% of all 259 adverse event reports for this drug.

Patients taking AMMONIA N 13 who experience depression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEPRESSION is a less commonly reported adverse event for AMMONIA N 13, but still significant enough to appear in the safety profile.

Other Side Effects of AMMONIA N 13

In addition to depression, the following adverse reactions have been reported for AMMONIA N 13:

• DRUG ABUSE — 7 reports
• COUGH — 6 reports
• CHEST PAIN — 5 reports
• DRUG INEFFECTIVE — 5 reports
• DYSPNOEA — 5 reports
• NAUSEA — 5 reports
• SUICIDE ATTEMPT — 5 reports
• VOMITING — 5 reports
• ACCIDENTAL EXPOSURE TO PRODUCT — 4 reports
• DRUG HYPERSENSITIVITY — 4 reports

Other Drugs Associated with DEPRESSION

The following drugs have also been linked to depression in FDA adverse event reports:

Does AMMONIA N 13 cause DEPRESSION?

DEPRESSION has been reported as an adverse event in 6 FDA reports for AMMONIA N 13. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEPRESSION with AMMONIA N 13?

DEPRESSION accounts for approximately 2.3% of all adverse event reports for AMMONIA N 13, making it one of the most commonly reported side effect.

What should I do if I experience DEPRESSION while taking AMMONIA N 13?

If you experience depression while taking AMMONIA N 13, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages